Patent ID: 8323687

Claim:
A pharmaceutical composition in gel dosage form for the treatment of osteoporosis, that includes biphosphonate as an active component, wherein the biphosphonate is incorporated in phospholipid vesicles formed from lipid and hydrophilic phases comprising ingredients with the following amounts, based on mass %: biphosphonate 0.01-2.0; egg lecithin 1.0-6.0; essential pine oil 0.05-0.2; camphor oil 0.01-1.0; olive oil 0.01-5.0; vitamin E 0.01-0.15; vitamin D 0.01-0.2; carbopol 0.4-0.6; NaOH 0.42; glycerin 2.0-4.0; nipagin 0.3; nipasol 0.1; and the rest, water.